Patient P-02576
Synthetic patientMETA-24 · Day 153 · 45–54 · F · baseline S17Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
57%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S17
- Day 29 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 29.
Primary contributors, last 14 days
- GI instability+30
- Inflammatory activity+22
- Nutritional resilience-13
- Toxicity+5
- Treatment adherence+2
What helped?
No interventions yet.
LIFE OS recommendation
Monitoring Escalation ME-01
82%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 100% showed improvement
- median effect visible after 3 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable81 min
stable · -2.8 vs previous 14 d
Sleep duration
Wearable6.2 h
worsening · -0.4 vs previous 14 d
Energy level
Daily log4.7/10
worsening · -0.8 vs previous 14 d
Steps
Wearable9,687
stable · -214 vs previous 14 d
GI burden
Companion33.4/100
worsening · +10.4 vs previous 14 d
Adherence
Companion92.8 %
stable · -2.0 vs previous 14 d
Sleep quality
Wearable45.1/100
worsening · -8.6 vs previous 14 d
Glucose, CGM daily mean
CGM132 mg/dL
stable · +1.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 62 from the failing basin, 26 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -9.7 next day on high-intake days · n 17
Would not help
- Keep alcohol lowGI +7.5 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-9.7supporter · 95%
- Alcohol+7.5detractor · 95%
- Insoluble fibre-1.5no signal · 23%
- Simple carbohydrates-1.4no signal · 18%
- Ultra-processed food+1.4no signal · 20%
- Dietary fat load-1no signal · 15%
- Caffeine-0.9no signal · 15%
- Histamine load+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓45
- WearableResting HR 77 bpm
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 70/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 64 ms
- Sleep
- 6.6 h
- Steps
- 9,630
- Resting HR
- 72 bpm
Daily log: GI score 33, nutritional resilience 60, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.